Skip to content

CIK 0001445283

KANT KINETA, INC./DE

Insider trading from SEC Form 4. Last filing Jul 2, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company

Signals

Open-market buys and sells at KINETA, INC./DE, scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

The last 61 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jun 30, 2025David Arkowitz
director
DDisposition to issuer
Common Stock
-16,571--0Jul 2, 2025
Jun 30, 2025Keith Baker
Chief Financial Officer
DDisposition to issuer
Common Stock
-247,933--0Jul 2, 2025
Jun 30, 2025Raymond J. Bartoszek
director
DDisposition to issuer
Common Stock
-31,000--0Jul 2, 2025
Jun 30, 2025David Arkowitz
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-12,500$0.00$00Jul 2, 2025
Jun 30, 2025Raymond J. Bartoszek
director
DDisposition to issuer
Common Stockindirect: By RLB Holdings Connecticut, LLC
-1,748,473--0Jul 2, 2025
Jun 30, 2025Keith Baker
Chief Financial Officer
DDisposition to issuer
Stock Option (Right to Buy)derivative
-2,663$0.00$00Jul 2, 2025
Jun 30, 2025Keith Baker
Chief Financial Officer
DDisposition to issuer
Stock Option (Right to Buy)derivative
-11,096$0.00$00Jul 2, 2025
Jun 30, 2025David Arkowitz
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-20,000$0.00$00Jul 2, 2025
Jun 30, 2025Raymond J. Bartoszek
director
DDisposition to issuer
Common Stockindirect: By son
-1,001--0Jul 2, 2025
Jun 30, 2025Keith Baker
Chief Financial Officer
DDisposition to issuer
Stock Option (Right to Buy)derivative
-40,037$0.00$00Jul 2, 2025
Jun 30, 2025Raymond J. Bartoszek
director
DDisposition to issuer
Common Stockindirect: By daughter
-1,000--0Jul 2, 2025
Jun 30, 2025Keith Baker
Chief Financial Officer
DDisposition to issuer
Stock Option (Right to Buy)derivative
-80,023$0.00$00Jul 2, 2025
Jun 30, 2025Raymond J. Bartoszek
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-12,500$0.00$00Jul 2, 2025
Jun 30, 2025Raymond J. Bartoszek
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-3,440$0.00$00Jul 2, 2025
Jun 30, 2025Raymond J. Bartoszek
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-6,192$0.00$00Jul 2, 2025
Jun 30, 2025Raymond J. Bartoszek
director
DDisposition to issuer
Stock Option (Right to Buy)derivative
-10,320$0.00$00Jul 2, 2025
Jun 23, 2025Shawn Iadonato
director
MOption exercise
Common Stock
+12,500$0.61$7,638687,730Jun 26, 2025
Jun 23, 2025Shawn Iadonato
director
MOption exercise
Common Stock
+225,000$0.36$81k912,730Jun 26, 2025
Jun 23, 2025Shawn Iadonato
director
FTax withholding
Common Stock
-52,353$0.26$14k860,377Jun 26, 2025
Jun 23, 2025Shawn Iadonato
director
MOption exercise
Stock Option (Right to Buy)derivative
-12,500$0.00$00Jun 26, 2025
Jun 23, 2025Shawn Iadonato
director
MOption exercise
Stock Option (Right to Buy)derivative
-225,000$0.00$00Jun 26, 2025
Jun 23, 2025Raymond J. Bartoszek
director
MOption exercise
Common Stock
+12,500$0.61$7,63829,706Jun 25, 2025
Jun 23, 2025Craig W. Philips
President and Secretary
MOption exercise
Common Stock
+225,000$0.36$81k285,811Jun 25, 2025
Jun 23, 2025Marion R Foote
director
MOption exercise
Common Stock
+12,500$0.61$7,638163,862Jun 25, 2025
Jun 23, 2025Scott J. Dylla
director
MOption exercise
Common Stock
+12,500$0.61$7,63816,500Jun 25, 2025
Jun 23, 2025Richard Peters
director
MOption exercise
Common Stock
+12,500$0.61$7,638100,597Jun 25, 2025
Jun 23, 2025Kimberlee C Drapkin
director
MOption exercise
Common Stock
+12,500$0.61$7,63812,500Jun 25, 2025
Jun 23, 2025Thierry Guillaudeux
Chief Scientific Officer
MOption exercise
Common Stock
+225,000$0.36$81k246,696Jun 25, 2025
Jun 23, 2025Keith Baker
Chief Financial Officer
MOption exercise
Common Stock
+225,000$0.36$81k241,880Jun 25, 2025
Jun 23, 2025David Arkowitz
director
MOption exercise
Common Stock
+12,500$0.61$7,63816,847Jun 25, 2025
Jun 23, 2025Keith Baker
Chief Financial Officer
FTax withholding
Common Stock
-47,647$0.26$12k194,233Jun 25, 2025
Jun 23, 2025Thierry Guillaudeux
Chief Scientific Officer
FTax withholding
Common Stock
-47,647$0.26$12k194,233Jun 25, 2025
Jun 23, 2025Raymond J. Bartoszek
director
FTax withholding
Common Stock
-4,706$0.26$1,22425,000Jun 25, 2025
Jun 23, 2025Richard Peters
director
FTax withholding
Common Stock
-4,706$0.26$1,22495,891Jun 25, 2025
Jun 23, 2025David Arkowitz
director
FTax withholding
Common Stock
-4,706$0.26$1,22412,141Jun 25, 2025
Jun 23, 2025Kimberlee C Drapkin
director
FTax withholding
Common Stock
-4,706$0.26$1,2247,794Jun 25, 2025
Jun 23, 2025Scott J. Dylla
director
FTax withholding
Common Stock
-4,706$0.26$1,22411,794Jun 25, 2025
Jun 23, 2025Craig W. Philips
President and Secretary
FTax withholding
Common Stock
-47,647$0.26$12k238,164Jun 25, 2025
Jun 23, 2025Marion R Foote
director
FTax withholding
Common Stock
-4,706$0.26$1,224159,156Jun 25, 2025
Jun 25, 2025Marion R Foote
director
AGrant or award
Common Stock
+6,000$0.00$0165,156Jun 25, 2025
Jun 25, 2025Raymond J. Bartoszek
director
AGrant or award
Common Stock
+6,000$0.00$031,000Jun 25, 2025
Jun 25, 2025Keith Baker
Chief Financial Officer
AGrant or award
Common Stock
+53,700$0.00$0247,933Jun 25, 2025
Jun 25, 2025David Arkowitz
director
AGrant or award
Common Stock
+6,000$0.00$018,141Jun 25, 2025
Jun 25, 2025Kimberlee C Drapkin
director
AGrant or award
Common Stock
+6,000$0.00$013,794Jun 25, 2025
Jun 25, 2025Richard Peters
director
AGrant or award
Common Stock
+6,000$0.00$0101,891Jun 25, 2025
Jun 25, 2025Craig W. Philips
President and Secretary
AGrant or award
Common Stock
+60,300$0.00$0298,464Jun 25, 2025
Jun 25, 2025Thierry Guillaudeux
Chief Scientific Officer
AGrant or award
Common Stock
+23,100$0.00$0217,333Jun 25, 2025
Jun 25, 2025Scott J. Dylla
director
AGrant or award
Common Stock
+6,000$0.00$017,794Jun 25, 2025
Jun 23, 2025Richard Peters
director
MOption exercise
Stock Option (Right to Buy)derivative
-12,500$0.00$00Jun 25, 2025
Jun 23, 2025Keith Baker
Chief Financial Officer
MOption exercise
Stock Option (Right to Buy)derivative
-225,000$0.00$00Jun 25, 2025
Jun 23, 2025Thierry Guillaudeux
Chief Scientific Officer
MOption exercise
Stock Option (Right to Buy)derivative
-225,000$0.00$00Jun 25, 2025
Jun 23, 2025Marion R Foote
director
MOption exercise
Stock Option (Right to Buy)derivative
-12,500$0.00$00Jun 25, 2025
Jun 23, 2025Scott J. Dylla
director
MOption exercise
Stock Option (Right to Buy)derivative
-12,500$0.00$012,500Jun 25, 2025
Jun 23, 2025Kimberlee C Drapkin
director
MOption exercise
Stock Option (Right to Buy)derivative
-12,500$0.00$00Jun 25, 2025
Jun 23, 2025David Arkowitz
director
MOption exercise
Stock Option (Right to Buy)derivative
-12,500$0.00$00Jun 25, 2025
Jun 23, 2025Craig W. Philips
President and Secretary
MOption exercise
Stock Option (Right to Buy)derivative
-225,000$0.00$00Jun 25, 2025
Jun 23, 2025Raymond J. Bartoszek
director
MOption exercise
Stock Option (Right to Buy)derivative
-12,500$0.00$00Jun 25, 2025
Jun 17, 2025Marion R Foote
director
MOption exercise
Common Stock
+8,158$0.14$1,142151,362Jun 20, 2025
Jun 17, 2025Marion R Foote
director
MOption exercise
Warrants (Right to Buy)derivative
-3,457$0.00$00Jun 20, 2025
Jun 17, 2025Marion R Foote
director
MOption exercise
Warrants (Right to Buy)derivative
-401$0.00$00Jun 20, 2025
Jun 17, 2025Marion R Foote
director
MOption exercise
Warrants (Right to Buy)derivative
-4,300$0.00$00Jun 20, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

KANT insider trading: KINETA, INC./DE | InsiderTell